Tempus AI, Inc. (Ticker: TEM) is a leading healthcare technology company based in Chicago, Illinois, specializing in the integration of artificial intelligence and data analytics to enhance medical decision-making and personalized treatment strategies. By leveraging comprehensive genomic data and clinical information, Tempus aims to accelerate advancements in precision medicine, ultimately improving patient outcomes in oncology and other therapeutic areas. The company's innovative approach positions it at the forefront of the rapidly evolving healthcare landscape, making it a compelling investment opportunity for institutional investors focused on transformative technologies in healthcare.